Pharmaceutical Sterility Testing Market to Decline from $1.02B in 2019 to $1B in 2020 - Ceasure of Pharmaceutical & Medical Devices Production due to COVID-19 has Impacted Short-Term Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Sterility Testing Global Market Report 2020-30: Covid 19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical sterility testing market is expected to decline from $1.02 billion in 2019 to $1 billion in 2020 at a compound annual growth rate (CAGR) of -3%. While the overall sterility testing market is a decline in 2020 due to COVID-19, some market segments (medical devices and drugs used for covid-19), will grow significantly. Ceasing of pharmaceutical and medical devices production due to COVID-19 has impacted the sterility testing market.

The market is expected to recover and reach $1.39 billion in 2023 at a CAGR of 8%. North America was the largest region in 2019. Increased in the number of drug launches and rising investment on research and development (R&D) contributed to the growth of pharmaceutical sterility testing market.

Companies in the pharmaceutical testing market are launching new pharmaceutical sterility testing products and services to increase its product portfolio and expand its presence in the market. The companies are launching technologically advanced products and well-equipped services to exploit growth potential of the rising pharmaceutical sterility market.

For instance, In 2019, RSSL launched a sterility testing service for pharmaceutical and medical device companies which offers fast, responsive and flexible test services. RSSL's new sterility testing service includes two methods, membrane filtration for aqueous, alcohol, solvent and oil-based products and direct inoculation tests for non-soluble to determine the presence of contaminating microorganisms in sterilized or aseptic drug products.

Similarly, in December 2018, Merck, a leading sterility testing device manufacturer, launched Steritest NEO Device, a convenient and effective sterility device used for pharmaceutical drug testing.

In August 2018, Sotera Health, a USA based pharmaceutical company, acquired Gibraltar Laboratories for an undisclosed amount. The acquisition is expected to expand the business of analytical testing capabilities of Sotera Health's Nelson Labs. Gibraltar Laboratories is an external provider of microbiological and analytical chemical tests that includes streilization services for pharmaceutical and medical device manufacturers.

Major players in the pharmaceutical sterility testing market are Pacific Biolabs, STRERIS Corporation, Boston Analytical, Gibraltar Laboratories, Sartorius, Solvias, SGS, Toxikon, Pace Analytical Services and Charles River Laboratories International.

Key Topics Covered

1. Executive Summary

2. Pharmaceutical Sterility Testing Market Characteristics

3. Pharmaceutical Sterility Testing Market Size And Growth

3.1. Global Pharmaceutical Sterility Testing Historic Market, 2015-2019, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Pharmaceutical Sterility Testing Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Pharmaceutical Sterility Testing Market Segmentation

4.1. Global Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

• Sterile Drugs
• Medical Devices
• Biologics and Therapeutics

4.2. Global Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

• Instruments
• Kits and Reagents
• Services

4.3. Global Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

• In-house
• Outsourcing

4.4. Global Pharmaceutical Sterility Testing Market, Segmentation By Test Type Outlook, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

• Sterility Testing
• Bioburden Testing
• Bacterial Endotoxin Testing

4.5. Global Pharmaceutical Sterility Testing Market, Segmentation By End- User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

• Compounding Pharmacies
• Medical Devices Companies
• Pharmaceutical Companies

5. Pharmaceutical Sterility Testing Market Regional And Country Analysis

5.1. Global Pharmaceutical Sterility Testing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5.2. Global Pharmaceutical Sterility Testing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Companies Mentioned

• bioMerieux
• Boston Analytical
• Charles River Laboratories International, Inc.
• Dynalabs
• Gibraltar Laboratories
• Infinity
• Merck KGaA
• Nelson Laboratories, Inc.
• Pace Analytical Services LLC
• Pacific Biolabs
• Rapid Micro Biosystems, Inc.
• Sartorius AG
• SGS AG
• SolviasAG
• Sotera Health LLC
• STRERIS Corporation
• Toxikon, Inc.
• Wuxi AppTec

For more information about this report visit https://www.researchandmarkets.com/r/uwxm0s